Monopoly: Cefpodoxime 200mg Dicloxacillin 500mg Combo

High Profit Margins on Dual-Action Antibiotics

Market Edge: Treat Difficult Infections

Secure Exclusive Territory for Flickdox DC

Low Investment, Full Sales Support
Start Your High-Demand Antibiotic Business Today

Home/Products /cefpodoxime-proxetil-200mg-dicloxacillin-500mg-tablet

Flickdox DC Tablet

Composition : Cefpodoxime Proxetil (200mg) + Dicloxacillin (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Flickdox DC Tablet (Cefpodoxime 200mg + Dicloxacillin 500mg) is a top product built for our PCD Pharma Franchise partners to earn maximum revenue.

This high-strength, dual-antibiotic combination is a clinical necessity for treating stubborn infections, which maximizes your sales revenue.

Why this High-Potency Combination is Your Key to Profit:

  1. High Demand, Superior Strength: The Cefpodoxime 200mg plus Dicloxacillin 500mg mix targets a wide range of tough, resistant infections. Doctors need this strength, which guarantees consistent, high sales volume for you.

  2. Rational Combination: This dual-action kills bacteria by attacking two separate pathways, making it highly effective where single drugs might fail. This clinical advantage builds doctor loyalty and secures repeat orders.

  3. Maximum Profit: Positioned as a strong, premium combination in the fast-moving anti-infective segment, this formula allows for excellent pricing and the highest profit margins in your territory.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition. Partner with us for full marketing support and reliable supply to turn this essential drug into guaranteed business growth.

Contact us today to secure this high-margin territory!

Read More

About the Product

Flickdox DC Tablet (Cefpodoxime 200mg + Dicloxacillin 500mg) is a top product built for our PCD Pharma Franchise partners to earn maximum revenue.

This high-strength, dual-antibiotic combination is a clinical necessity for treating stubborn infections, which maximizes your sales revenue.

Why this High-Potency Combination is Your Key to Profit:

  1. High Demand, Superior Strength: The Cefpodoxime 200mg plus Dicloxacillin 500mg mix targets a wide range of tough, resistant infections. Doctors need this strength, which guarantees consistent, high sales volume for you.

  2. Rational Combination: This dual-action kills bacteria by attacking two separate pathways, making it highly effective where single drugs might fail. This clinical advantage builds doctor loyalty and secures repeat orders.

  3. Maximum Profit: Positioned as a strong, premium combination in the fast-moving anti-infective segment, this formula allows for excellent pricing and the highest profit margins in your territory.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition. Partner with us for full marketing support and reliable supply to turn this essential drug into guaranteed business growth.

Contact us today to secure this high-margin territory!

May include diarrhea, nausea, abdominal pain, and potential allergic reactions.

Treatment of bacterial infections such as respiratory and urinary tract infections.

Consult your healthcare provider before use, especially if you have a history of allergies to antibiotics.

Store in a cool, dry place away from direct sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation